Business Wire

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration

Share

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries to discover therapeutic antibodies against multiple targets provided by Boehringer Ingelheim.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210909005527/en/

“Boehringer Ingelheim believes Twist’s ability to generate potent, diverse therapeutic antibodies by mining its comprehensive libraries, combined with our extensive capabilities and experience in drug discovery and development, will enable us to deliver breakthrough opportunities to patients,” said Clive R. Wood, Ph.D., Senior Corporate Vice President and Global Head of Discovery Research at Boehringer Ingelheim. “We look forward to working with Twist on molecular targets in a broad range of disease areas,” added Wood.

Under the terms of the agreement, Twist Biopharma, a division of Twist, will utilize its “Library of Libraries,” a panel of synthetic antibody phage display libraries derived only from sequences that exist in the human body, to identify potential therapeutic antibody candidates. Twist and Boehringer Ingelheim will work together to validate and optimize any resulting new antibody candidates, which could be researched against a range of therapeutic areas. Boehringer Ingelheim retains exclusive worldwide rights to develop and commercialize any therapeutic antibodies discovered as part of the collaboration.

Twist will receive an upfront payment for each program entry. In addition, Twist has the potential to earn up to a total of $710 million in success-based clinical, regulatory and commercial milestone payments for the multiple target discovery programs.

“This discovery collaboration with Boehringer Ingelheim covering numerous targets truly illustrates the power of our antibody libraries. We have the ability to generate precise antibodies to a diverse range of targets, which together with Boehringer Ingelheim’s strength in drug development capabilities, could mean multiple new, more personalized treatments in the future for patients,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist.

Legal Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained herein, including without limitation Twist’s ability to discover novel therapeutic antibodies against multiple targets and to achieve any of the clinical, regulatory or commercial milestones, are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist Bioscience’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risks and uncertainties of the ability to attract new customers and retain and grow sales from existing customers; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology could make the products Twist Bioscience is developing obsolete or non-competitive; the retention of employees of acquired companies and the ability of Twist Bioscience to successfully integrate acquired companies and to achieve expected benefits, risks of third party claims alleging infringement of patents and proprietary rights or seeking to invalidate Twist Bioscience’s patents or proprietary rights; and the risk that Twist Bioscience’s proprietary rights may be insufficient to protect its technologies. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Twist Bioscience’s business in general, see Twist Bioscience’s risk factors set forth in Twist Bioscience’s Quarterly Report Form 10-Q filed with the Securities and Exchange Commission on August 9, 2021 and subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Twist Bioscience specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Please click on the following link for ‘Notes to Editors’:

http://www.boehringer-ingelheim.com/press-release/new-therapeutic-antibody-discovery-collaboration

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Twist Bioscience
Angela Bitting
SVP, Corporate Affairs
925- 202-6211
media@twistbioscience.com

Boehringer Ingelheim
Dr. Reinhard Malin
Head of Communications Innovation Unit
Boehringer Ingelheim Corporate Center GmbH
Media + PR
P: +49 6132 77-90815
press@boehringer-ingelheim.com

Linda Ruckel
Senior Associate Director, Media and Corporate Reputation
Boehringer Ingelheim U.S.
Media + PR
P: +1 203-791-6672
press@boehringer-ingelheim.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Velodyne Lidar Announces Multi-Year Supply Agreement with TOPODRONE21.9.2021 10:00:00 CEST | Press release

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a multi-year agreement to provide its lidar sensors to TOPODRONE, which is based in Switzerland and develops affordable, high-precision solutions for aerial surveys. Using Velodyne lidar sensors has enabled TOPODRONE to bring high-precision mapping and 3D modeling to demanding environments including farms, forests, infrastructure and more to support development that advances economic and sustainability goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005316/en/ Velodyne Lidar announced a multi-year agreement to provide its lidar sensors to TOPODRONE, which is based in Switzerland and develops affordable, high-precision solutions for aerial surveys. Using Velodyne lidar sensors has enabled TOPODRONE to bring high-precision mapping and 3D modeling to demanding environments including farms, forests, infrastructure and more. (Photo: TOPODRONE) Velodyne (Hall:

CSC Adds Two Industry Leaders in Luxembourg; Secures Fund Administration and Depositary Licenses for Additional Services21.9.2021 10:00:00 CEST | Press release

CSC, the world’s leading provider of business, legal, tax, and digital brand services, has significantly expanded its operations in Luxembourg by securing new fund administration and depositary licenses and adding two experienced executives to help lead its growth in the market. This further extends CSC’s European fund administration and depositary offerings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005284/en/ Yves Cheret (Photo: Business Wire) With these key hires, clients will benefit from the addition of more than 30 years of combined industry expertise to CSC’s long-standing service offerings, including a range of alternative investment, capital markets, and corporate solutions. In addition, these new licenses will open new and essential services to clients in Luxembourg, yet another key European financial center in CSC’s growing footprint. Veteran talent, local expertise Pierre Mifsud joins as managing direc

Square Launches Integrated, Omnichannel Solutions For Businesses in France21.9.2021 09:00:00 CEST | Press release

Today Square, the globally trusted software, payments, and hardware solution for businesses of all sizes, launches in France. Following a successful Early Access Programme, now small businesses and large enterprises across France can access Square’s innovative ecosystem with the tools they need to start, run, grow, and adapt their businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005137/en/ Square Launches Integrated, Omnichannel Solutions For Businesses in France (Photo: Business Wire) “I’ve been using Square’s products both on-site and online over the past few months and it has revolutionised how I run my business,” said Anne-Laure Fonrose, Founder of Tatie Nanna. “Having an integrated, omnichannel payment solution means our customers can pay in any way that suits them. It’s all been easy to set-up and run, the product looks great on site, and the connectivity is super-fast which helps avoid long queues. I’m

RedIRIS taps ADVA and SIA to upgrade national research network21.9.2021 09:00:00 CEST | Press release

ADVA (FSE: ADV) and SIA, Indra’s cybersecurity company, today announced that RedIRIS is deploying ADVA’s technology to create a robust, high-capacity research and education network (NREN). The new long-haul backbone infrastructure connects universities and research facilities across Spain, enabling educators and scientists to share huge data sets and harness bandwidth-intensive applications. Built on the ADVA FSP 3000 and monitored by the ADVA ALM fiber assurance solution, the network carries services at speeds up to 200Gbit/s. Featuring ADVA’s ROADM technology and QuadFlex™ line cards, the open solution has given RedIRIS an easy way to migrate from legacy technology to flexible, high-performance connectivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005058/en/ ADVA is helping RedIRIS create a long-haul research and education network that stretches throughout Spain (Photo: Business Wire) “Our new transport system

Turquoise Plato Connects to OpenFin to Simplify Complexity on the Buy-Side Trader Desktop21.9.2021 09:00:00 CEST | Press release

OpenFin, the operating system (OS) for enterprise productivity, today announced that LSEG’s (London Stock Exchange Group) Turquoise Plato is connecting to OpenFin in response to the industry need for workflow efficiencies, application interoperability, and a more unified desktop experience for the buy-side and member firm users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005467/en/ Turquoise has a proven track record in delivering innovation and liquidity opportunities to the market, with Turquoise Plato Block Discovery™ having seen record levels of block trading activity on Turquoise® and Turquoise Europe™ in 2020. With this collaboration, Turquoise is continuing to deliver on its mission to identify efficient, collaborative operating models that reduce the implicit cost of trading, contribute to long-term investment returns and drive sustainable growth. Turquoise on OpenFin™ delivers an insightful data feed direc

Total Telecom: LG U+ Leads South Korea 5G Mobile Network Performance21.9.2021 08:30:00 CEST | Press release

Total Telecom features a new Umlaut 2021 audit report, which found that LG U+ outperforms KT and SKT Telecom (SKT) in Seoul, and achieved the highest Umlaut score despite owning significantly less amount of spectrum when compared with its rivals. It is the first time that Umlaut analysed mobile networks in South Korea regarding 5G mobile network performance. Umlaut scored networks under test basis data and voice quality. In Seoul, LG U+ took the leading place with a total score of 979 out of 1000, followed by KT and SKT, which have achieved total scores of 971 and 952 respectively. Like what the report has stated, LG U+ is equipped with the spectrum at 50MHz LTE, which is in lower frequency when compared to 55MHz for KT and 75MHz for SKT. Same situation also applies to the 5G New Radio (NR) spectrum, in which LG U+ is with 80 MHz, but both KT and SKT are with 100MHz. Despite equipping the spectrum with a lower frequency, LG U+ has the best performance in 5G user experience and 5G avail

Spotify Uses ReadSpeaker to Power Custom Voices for Car Thing Smart Player21.9.2021 08:00:00 CEST | Press release

ReadSpeaker, the most trusted, independent digital voice partner for global businesses, today announced that Spotify uses ReadSpeaker’s text-to-speech (TTS) technology to deliver custom voices for Spotify’s newest exploration in the US - a limited release of Car Thing, a smart player for your car. ReadSpeaker’s technology currently powers the custom voice available in Car Thing. Similar to the way the business world evolved from relying on websites to mobile apps as smartphones became popular, as the world moves beyond touchscreens and into a touchless future, consumers will become increasingly reliant on voice commands. ReadSpeaker believes that all brands have their own independent voice assistant, and custom voices will be critical in enabling brands to stand apart from competitors. Spotify uses ReadSpeaker’s technology and the ReadSpeaker VoiceLab because of the company’s deep expertise in custom branded voices powered by deep neural networks. Further, ReadSpeaker’s embedded and cl

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom